Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.
about
Unconventional anticancer agents: a systematic review of clinical trialsPancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancerEffects of Flavonoids from Food and Dietary Supplements on Glial and Glioblastoma Multiforme CellsGene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.Hormonal treatment for prostate cancer.Targeting angiogenesis with integrative cancer therapies.The treatment of prostate cancer: an overview of current options.Herbal supplement PC-Spes for prostate cancer.Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumorsEthanol extract of Remotiflori radix induces endoplasmic reticulum stress-mediated cell death through AMPK/mTOR signaling in human prostate cancer cells.Safety surveillance of traditional Chinese medicine: current and futurePC-SPES: a brief overview.Is there a role for chemotherapy in prostate cancer?Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.Herbal Formulation C168 Attenuates Proliferation and Induces Apoptosis in HCT 116 Human Colorectal Carcinoma Cells: Role of Oxidative Stress and DNA Damage.Inhibitory Effects of PC-SPESII Herbal Extract on Human Breast Cancer Metastasis.Application of transcriptomics in Chinese herbal medicine studies.Down-regulation of androgen-receptor and PSA by phytochemicals.Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest.Selective aromatase inhibition for patients with androgen-independent prostate carcinoma.Scutellaria baicalensis and Cancer Treatment: Recent Progress and Perspectives in Biomedical and Clinical Studies.Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells
P2860
Q24545903-66537E71-1E93-4A31-BD1A-E52618D9B122Q24631880-9EAF3912-682C-4384-8F75-AE4DF7AB4B6FQ26778024-645E1386-5D1B-467A-B6BC-CCA5DAF49655Q30310558-21BC2310-1077-4E94-B8C3-9F3D3F01E620Q34167174-6B4C6590-673F-4D2E-86BE-ED892AFDA354Q34495463-A11FF64D-F922-4839-BBAB-8B973711855DQ34552438-BA27183D-38EC-4E7B-B5FD-934AF3D17FE3Q34615655-CD329A69-E37A-4C71-96BB-2F207F870A5EQ34787754-86D19ABC-E9E7-44C9-9622-ED5FDFBF3AE4Q35070133-2144D90D-16D4-4A63-B6FB-5817D01B14C0Q35142633-AC9D4A89-241B-4423-B146-48C9CEBAFD34Q35604672-BAB2DCF3-F870-4602-A3D3-BA6375C2C0E8Q35776921-87B42A92-246C-4799-BE85-6D875DD8BD89Q35840331-CF24B5A0-746A-40D9-989E-173048099E29Q36538227-8FC2C1A6-AA6A-48BB-BE70-6819AB0E9468Q37002882-2C36B01A-FD0C-48CB-8C2A-EEA5F477F14CQ37618136-B937EAEF-11A1-46A4-A0BB-C0B9138F5A26Q40023730-FEDD3F2C-391E-454F-8B06-772ACC83D998Q40762945-EA77434B-8E47-4B67-9B5F-7953D268A1FCQ44197094-25AF3D93-EFC1-4118-9974-BCBBE671BFE8Q50115741-1D0B534F-C70F-4FAE-A46B-5ACE83C7213CQ57066655-2A67EBFD-C3DD-4A10-A282-E37D4911CA52
P2860
Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Prospective trial of the herba ...... h progressive prostate cancer.
@en
Prospective trial of the herba ...... h progressive prostate cancer.
@nl
type
label
Prospective trial of the herba ...... h progressive prostate cancer.
@en
Prospective trial of the herba ...... h progressive prostate cancer.
@nl
prefLabel
Prospective trial of the herba ...... h progressive prostate cancer.
@en
Prospective trial of the herba ...... h progressive prostate cancer.
@nl
P2093
P1476
Prospective trial of the herba ...... h progressive prostate cancer.
@en
P2093
G Grossfeld
K Shinohara
M W Frohlich
Z Rozenblat
P304
P356
10.1200/JCO.2000.18.21.3595
P407
P577
2000-11-01T00:00:00Z